Search results
Moderna's stock climbs on report that bird-flu vaccine funding is near
Morningstar· 1 day agoModerna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu ...
US nears deal to fund Moderna’s bird flu vaccine trial, FT reports
KFGO· 1 day ago(Reuters) - The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's mRNA...
Moderna Makes Big Play for Big Tech Talent
The Wall Street Journal· 3 days agoCIO Brad Miller has been replacing IT outsourced during the pandemic with a full-time in-house staff as the biotech looks to roll out 15 new products...
Moderna rises on FT report about bird flu vaccines By Investing.com
Investing.com· 1 day agoShares of Moderna (NASDAQ:MRNA) are up 2.8% premarket Thursday after a report from The Financial...
Moderna and this solar name are among the most overbought stocks after a record-setting week
CNBC· 7 days agoIt may be time for investors to trim positions in overbought names after the stock market reached...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 3 days agoDespite the declining top line, shares of Moderna MRNA continue to soar thanks to its encouraging...
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 43% Discount?
Simply Wall St. via Yahoo Finance· 6 days agoKey Insights The projected fair value for Moderna is US$294 based on 2 Stage Free Cash Flow to...
...Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD...
Benzinga· 1 day agoOn Wednesday, Ark Invest, led by the influential investor Cathie Wood, executed notable trades...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports By Reuters
Investing.com· 1 day agoModerna and the U.S. Department of Health and Human Services (HHS) did not immediately respond to...
Salesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise By Investing.com
Investing.com· 1 day agoSalesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise